What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Purpose Tumor regression grade (TRG) is predictive of therapeutic response in rectal cancer patients after chemoradiotherapy (CRT) followed by curative resection. However, various TRG systems have been suggested, with subjective categorization, resulting in interobserver variability. This study compared the prognostic validity of four different TRG systems in order to identify the most ideal TRG system. Materials and Methods This study included 933 patients who underwent preoperative CRT and curative resection. Primary tumors alone were graded according to the American Joint Committee on Cancer (AJCC), Dworak, and Ryan TRG systems, and both primary tumors and regional lymph nodes were graded according to a modified Dworak TRG system. The ability of each TRG system to predict recurrence-free survival (RFS) and overall survival (OS) was analyzed using chisquare and C statistics. Results All four TRG systems were significantly predictive of both RFS and OS (p < 0.001 each), however none was a better predictor of prognosis than ypStage. Among the four TRGs, the mDworak TRG system was a better predictor of RFS and OS than the AJCC, Dworak, and Ryan TRG systems, and both the chi-square and C statistics were higher for the former, although the differences were not statistically significant. The combination of ypStage and the modified Dworak TRG better predicted RFS and OS than ypStage alone. Conclusion The modified Dworak TRG system for evaluation of entire tumors including regional lymph nodes is a better predictor of survival than current TRG systems for evaluation of the primary tumor alone.
Abstract
Purpose Tumor regression grade (TRG) is predictive of therapeutic response in rectal cancer patients after chemoradiotherapy (CRT) followed by curative resection. However, various TRG systems have been suggested, with subjective categorization, resulting in interobserver variability. This study compared the prognostic validity of four different TRG systems in order to identify the most ideal TRG system. Materials and Methods This study included 933 patients who underwent preoperative CRT and curative resection. Primary tumors alone were graded according to the American Joint Committee on Cancer (AJCC), Dworak, and Ryan TRG systems, and both primary tumors and regional lymph nodes were graded according to a modified Dworak TRG system. The ability of each TRG system to predict recurrence-free survival (RFS) and overall survival (OS) was analyzed using chisquare and C statistics. Results All four TRG systems were significantly predictive of both RFS and OS (p < 0.001 each), however none was a better predictor of prognosis than ypStage. Among the four TRGs, the mDworak TRG system was a better predictor of RFS and OS than the AJCC, Dworak, and Ryan TRG systems, and both the chi-square and C statistics were higher for the former, although the differences were not statistically significant. The combination of ypStage and the modified Dworak TRG better predicted RFS and OS than ypStage alone. Conclusion The modified Dworak TRG system for evaluation of entire tumors including regional lymph nodes is a better predictor of survival than current TRG systems for evaluation of the primary tumor alone.
참고문헌 (25)
- Quah HM, "Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation", Cancer, 113, pp.57~64 (2008)
- Hermanek P, "Prognosis of rectal carcinoma after multimodal treatment : ypTNM classification and tumor regression grading are essential", Anticancer Res, 33, pp.559~566 (2013)
- Kim DW, "Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?", Cancer, 106, pp.1694~1700 (2006)
- Vecchio FM, "The relationship of pathologic tumor regression grade(TRG)and outcomes after preoperative therapy in rectal cancer", Int J Radiat Oncol Biol Phys, 62, pp.752~760 (2005)
- Edge SB, "AJCC cancer staging manual" (2010), Springer-Verlag
- Greene FL, "AJCC cancer staging manual" (2002), Springer-Verlag
- Fleming ID, "AJCC cancer staging manual" (1997), Lippincott-Raven Publishers
- Lee SD, "Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection", Eur J Surg Oncol, 38, pp.478~483 (2012)
- Tsai CJ, "Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma", Cancer, 117, pp.3713~3722 (2011)
- Chetty R, "International study group on rectal cancer regression grading : interobserver variability with commonly used regression grading systems", Hum Pathol, 43, pp.1917~1923 (2012)
- Ryan R, "Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer", Histopathology, 47, pp.141~146 (2005)
- Dworak O, "Pathological features of rectal cancer after preoperative radiochemotherapy", Int J Colorectal Dis, 12, pp.19~23 (1997)
- Mandard AM, "Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma : clinicopathologic correlations", Cancer, 73, pp.2680~2686 (1994)
- Bosman FT, "WHO classification of tumours of the digestive system" (2010), IARC Press
- Balakrishnan N, "Handbook of statistics: advances in survival analysis" (2004), Elsevier
- Rullier A, "Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma", Am J Surg Pathol, 34, pp.562~568 (2010)
- Suarez J, "Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer", Colorectal Dis, 10, pp.563~568 (2008)
- Rodel C, "Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer", J Clin Oncol, 23, pp.8688~8696 (2005)
- Rodel C, "Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer : initial results of the German CAO", ARO, Lancet Oncol, pp.2012, 13[DOI]
- Maas M, "Adjuvant chemotherapy in rectal cancer : defining subgroups who may benefit after neoadjuvant chemoradiation and resection : a pooled analysis of 3, 313 patients", Int J Cancer, 137, pp.212~220 (2015)
- Yeo SG, "Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer:long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01)", Ann Surg, 252, pp.998~1004 (2010)
- Huebner M, "Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy", World J Surg, 36, pp.675~683 (2012)
- Trakarnsanga A, "Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment", J Natl Cancer Inst, 106, pp.248~ (2014)
- Hong YS, "Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy(ADORE) : an open-label, multicentre, phase 2, randomised controlled trial", Lancet Oncol, 15, pp.1245~1253 (2014)
- Park SY, "Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?", Histopathology, 59, pp.650~659 (2011)